Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Mar 14 2025

Full Issue

Longer Looks: Interesting Reads You Might Have Missed

Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on sickle cell anemia, Xanax, microplastics, covid, and more.

CBS News: Long Island Man Is First In New York History To Be Cured Of Sickle Cell Anemia 

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain from debilitating sickle cell anemia. "Sickle cell was like a blockade for me, but now it's just like a wall that I just jumped over," he said. He is now making medical history in New York state. (McLogan, 3/13)

The Wall Street Journal: Generation Xanax: The Dark Side Of America’s Wonder Drug 

Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and intense physical pain. (Ramachandran and McKay, 3/13)

The Washington Post: How Microplastics Could Be Affecting Our Food Supply

Microplastics are floating in the air around us, surging through rivers and streams, and burrowing deep into soils. And now, a new study suggests that all those tiny pieces of plastic are also disrupting the growth of plants. A paper published in the Proceedings of the National Academy of Sciences on Monday found that the tiny plastic particles could be slashing photosynthesis rates globally. Microplastics, the scientists estimated, are responsible for a reduction in photosynthesis of 7 to 12 percent worldwide in plants and algae. That cut in photosynthesis, the researchers warned, could also impact large-scale crops that humans depend on, such as wheat, corn and rice. (Osaka, 3/13)

The New York Times: Do We Age Steadily, Or In Bursts? What Scientists Know So Far

New technologies are giving scientists a better understanding of how the process actually works. (Ravindranath, 3/6)

The New York Times: ‘Let’s Not Talk About It’: 5 Years Later, China’s Covid Shadow Lingers

People who endured the longest Covid restrictions in the world are still grappling with what they lost: their loved ones, their livelihoods, their dignity. (Wang, 3/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF